enVVeno Medical (NVNO) Long-Term Debt Repayments (2018)

enVVeno Medical (NVNO) recorded quarterly Long-Term Debt Repayments of $850000.0 in Q2 2018, up 209.09% quarter-over-quarter from $275000.0 in Q1 2018.

enVVeno Medical (NVNO) Long-Term Debt Repayments (2018) Analysis & Trends

enVVeno Medical's Long-Term Debt Repayments history runs 1 years deep, the most recent figure standing at $850000.0 for Q2 2018.

  • In Q2 2018, Long-Term Debt Repayments changed N/A year-over-year to $850000.0; the TTM figure through Dec 2018 stood at $1.1 million (changed N/A YoY), while the FY2018 annual figure was $1.1 million, changed N/A from the prior year.
  • Long-Term Debt Repayments was $850000.0 for Q2 2018 at enVVeno Medical, up from $275000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $850000.0 in Q2 2018 to a low of $275000.0 in Q1 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Abbott Laboratories 157.80 Bn 151.14 Bn 6.27 Bn 1.42 Bn
2 Stryker 115.54 Bn 112.66 Bn 3.81 Bn 1.00 Bn
3 Medtronic 103.44 Bn 95.27 Bn 5.76 Bn -
4 Boston Scientific 72.38 Bn 71.17 Bn 3.61 Bn -
5 Edwards Lifesciences 49.76 Bn 46.09 Bn 1.29 Bn -
6 Dexcom 29.53 Bn 28.42 Bn 750.30 Mn -
7 GE HealthCare Technologies 29.51 Bn 27.44 Bn 1.98 Bn -
8 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
9 Steris 20.69 Bn 20.27 Bn 697.10 Mn -
10 enVVeno Medical 6.68 Mn 6.68 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2018 850,000.00
Jun 30, 2018 850,000.00
Mar 31, 2018 275,000.00
Mar 31, 2018 275,000.00